SKI Market

A+| A| A-|

Indian Indices

Sensex

77,054.94 -561.46
( -0.72%)

Global Indices

Nasdaq

52,524.20 -133.81
(-0.25%)

Dow Jones

7,536.77 -59.62
(-0.78%)

Hang Seng

67,669.68 426.95
(0.63%)

Nikkei 225

10,494.06 -3.23
(-0.03%)

Forex

USD-INR

95.25 -0.20
(-0.21%)

EUR-INR

108.70 -0.40
(-0.37%)

GBP-INR

127.58 -0.36
(-0.28%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Kimia Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530313

INE285U01025

3.7455607

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

21.02

156.13

EPS(TTM)

Face Value()

Div & Yield %

1.57

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	118.92	104.88	128.52	124.90	132.71	106.29
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	118.92	104.88	128.52	124.90	132.71	106.29
Other Income	1.32	1.64	1.21	0.93	2.46	0.96
Stock Adjustments	3.68	-7.90	10.36	3.77	6.27	-1.15
Total Income	123.92	98.62	140.09	129.60	141.44	106.10
EXPENDITURE :
Raw Materials	74.55	67.36	106.39	96.03	103.13	79.09
Power & Fuel Cost	5.66	5.25	7.29	6.54	4.54	3.21
Employee Cost	13.68	15.15	16.40	15.08	14.09	10.80
Other Manufacturing Expenses	1.61	1.93	2.93	2.40	2.64	1.74
Selling & Administrative Expenses	6.67	7.22	7.04	6.16	4.88	3.76
Miscellaneous Expenses	0.19	0.55	4.85	1.82	1.33	2.08
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	102.35	97.46	144.90	128.04	130.61	100.68
Operating Profit	21.57	1.16	-4.81	1.56	10.84	5.42
Interest	4.56	5.05	4.25	3.64	3.39	2.53
Gross Profit	17.01	-3.89	-9.06	-2.08	7.45	2.89
Depreciation	3.38	3.29	3.33	2.94	1.91	1.66
Profit Before Tax	13.63	-7.18	-12.39	-5.02	5.54	1.23
Tax	0.00	0.00	0.00	0.00	0.00	-0.16
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.02	-1.88	-3.04	-1.32	0.43	0.00
Reported Net Profit	9.61	-5.31	-9.35	-3.70	5.10	1.38
Extraordinary Items	0.00	0.00	-1.05	0.08	0.07	-0.01
Adjusted Net Profit	9.61	-5.31	-8.30	-3.78	5.03	1.39
Adjustment below Net Profit	0.02	0.18	-0.07	0.16	-0.04	0.00
P & L Balance brought forward	-10.49	-5.35	4.07	7.62	2.56	1.23
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-0.85	-10.49	-5.35	4.07	7.62	2.61
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	2.03	-1.12	-1.98	-0.78	1.08	0.30
Earnings Per Share(Adj)-Unit Curr	2.03	-1.12	-1.98	-0.78	1.08	0.30
Book Value-Unit Curr	2.11	0.07	1.15	3.15	3.90	2.86
Book Value(Adj)-Unit Curr	2.11	0.07	1.15	3.15	3.90	2.86

77,054.94 -561.46 ( -0.72%)

52,524.20 -133.81 (-0.25%)

7,536.77 -59.62 (-0.78%)

67,669.68 426.95 (0.63%)

10,494.06 -3.23 (-0.03%)

95.25 -0.20 (-0.21%)

108.70 -0.40 (-0.37%)

127.58 -0.36 (-0.28%)

0.59 0.00 (0.19%)